The original success of Sildenafil undeniably revolutionized the drug landscape, but betting in companies heavily reliant on generic versions presents a uncertain picture. Despite early earnings were substantial, the expiration of patents and the rise of discounted alternatives have eroded market share. Therefore, a thorough analysis of current inc